Meanwhile, PRMT1 can facilitate the asymmetric methylation modification of EZH2, enhancing its protein stability and promoting the EMT process of breast cancer cells, which ultimately leads to breast cancer metastasis [21]. The gene discussed is EZH2; the disease is breast carcinoma.